申请人:CANCER REC TECH LTD
公开号:WO2009156735A2
公开(公告)日:2009-12-30
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.